BamSEC and AlphaSense Join Forces
Learn More

Myriad Genetics Inc. – Material Contracts

NASDAQ: MYGN    
Share price (7/7/26): $5.86    
Market cap (7/7/26): $553 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 21 pages Myriad Genetics, Inc. 2026 Employee, Director and Consultant Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 6 pages Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan
12/34/56
EX-10.4
from 10-Q 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 9 pages Separation Agreement and Release of Claims
12/34/56
EX-10.4
from 10-Q 2 pages Myriad Genetics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 8-K 27 pages Pledge and Security Agreement
12/34/56
EX-10.1
from 8-K 11 pages Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan as Amended
12/34/56
EX-10.10
from 10-Q 9 pages Myriad Genetics, Inc. Restricted Stock Unit Award Notice
12/34/56
EX-10.9
from 10-Q 9 pages Myriad Genetics, Inc. Restricted Stock Unit Award Notice
12/34/56
EX-10.6-2
from 10-K 7 pages Fifth Addendum to Assurex Health, Inc. Lease Agreement at 6000 Mason-Montgomery Road
12/34/56
EX-10.6-1
from 10-K 11 pages Lease Agreement
12/34/56
EX-10.4-2
from 10-K 4 pages Second Amendment to Lease
12/34/56
EX-10.5
from 8-K 7 pages Consulting Agreement
12/34/56
EX-10.4
from 8-K 12 pages Severance and Change of Control Agreement
12/34/56
EX-10.3
from 8-K 12 pages Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 12 pages Severance and Change of Control Agreement
12/34/56
EX-10.1
from 8-K 12 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.19
from 10-K 12 pages Separation and Consulting Agreement and Release of Claims
12/34/56
EX-10.18
from 10-K 11 pages Separation and Consulting Agreement and Release of Claims
12/34/56
EX-10.17
from 10-K 12 pages Executive Employment Agreement
12/34/56